March 30, 2007Implications Of New STEP-BD Study On Anti-DepressantsAs I noted yesterday, a new NIMH-sponsored study of anti-depressant use in bipolar disorder (or bipolar depression, if you prefer) showed that placebo outperformed anti-depressants in treating bipolar depression in patients already taking a mood stabilizer. Twenty-seven percent of patients getting a placebo held off depression for at least 8 weeks during the 26-week study while anti-depressants only worked in 23.5 percent of patients. The study was just published in the New England Journal of Medicine. If you want to read it for yourself, it's actually a freebie for now. It's as big a landmark study as the initial CATIE paper and drives a stake through the heart of the clinical practice of giving an anti-depressant to people with bipolar disorder. We've known for at least a decade that that's not likely to produce good results, but it's nice to have some academic cred for such assertions. We'll see how that translates into the real clinical world, but it is very bad news for anti-depressant makers. A lot of their sales come from bipolars. Meanwhile, I'd guess that there were high fives 'round the offices of Glaxo Smith Kline and AstraZeneca. GSK makes Lamictal and AZ makes Seroquel. Both have been marketed heavily as bipolar drugs that work on bipolar depression. I'll avoid nit-picking on either for now, especially since AZ is the focus of a Congressional investigation for its handling of Seroquel (as is Eli Lilly). Enjoy your day of good news and new market segmentation opportunities! No phone booth ads though guys, OK? My small complaints about the study are that it didn't break out response rates between Paxil (ironically, made by GSK in its patented form) and Wellbutrin. Nor did the study present data on how many of the people who saw an 8-week remission on either drug later relapsed. Maybe such data will be in a forthcoming paper. I've long been leery of the argument that depression in bipolar disorder is so wildly different from unipolar depression, especially since the 23.5 percent remission rate here is not so much different from the 30 percent remission rate in the first STAR*D round. But then again those weren't BPI or II patients. So maybe there is a difference of some kind after all. Posted by Philip Dawdy at March 30, 2007 12:03 AM
del.icio.us
Digg it
reddit
Comments
Hi Phil, I applaud your thorough analysis of the NEJM study and your reference to STAR*D. I have nicknamed the STAR*D study "Two strikes and you're out". If a patient has failed two adequate trials of two different antidepressants, then the patient is highly likely to fail antidepressants "three, four and five, etc." I was saved from a life of chronic depression thanks to vagus nerve stimulation therapy. www.MyDepressionSpace.com Posted by: Charles Donovan at March 30, 2007 04:03 AMYes, I absolutely believe this story, and am really glad you posted it. I've experienced both - unipolar and bipolar depression, and there's a *huge* difference. Bipolar depression is much worse in its' own way - not to alienate anyone who has only experienced unipolar depression. It's just DIFFERENT. They say that physicians can even tell by physical appearance those that have uni- versus bi- depression (I wish I had the link now...) Honestly, it really is different.... Posted by: KansasSunflower at March 30, 2007 04:12 AMI agree with most of what you've said, but think these two points are worth considering: 1. Perhaps this is an example of how science is exponential: we know more now than we did, say 5 years ago. 2. This is an example of how NIH is doing good things. This landmark study, like CATIE, is public money well spent. Posted by: Steve at March 30, 2007 05:40 AMGreat article It never ceases to amaze me though how depression/bi-polar depression and unibipolar depression are still being tested for treatment with antidepressants or any other chemicals for that matter. Depression is primarily an emotional/spiritual disconnection. The brain chemistry changes are purely a result and symptom of that disconnection.It is the brains response. And there is nothing unnatural about it.Granted, there are possibly some factors predetermining an individuals likelyhood of developing depression or bi-polar depression( genetics etc), but for the most part, it is a learned behaviour usually developed in adolesence or childhood and it is a natural response and reaction to truama. In essence it is a shutting down of the bodies systems and it originates as a protection mechanism.
The danger with Biological Psychiatry is that it is tinkering with neurons, brain chemicals and synapses, which are the symptom of the "depression" and by doing this they are recklessly playing god. All these new drugs, from Paxil/Prozac to Risperadal/ Lamictal and Zyprexa were only originally tested in short term clinical trials for short-term efficacy, benefit and performance. The public, who have been prescribed these drugs in large quantities for the past 20 years or so, have been the long-term clinical trial study. It is a disgrace what biological psychiatry has gotten away with and it is a disgrace how Psychiatry itself has become just another commercial wing of the pharmaceutical companies. Psychiatry is a regime, and that regime survives solely because it has the backing of the drugs industry. Without the drugs industry, psychiatry would not exist in this day and age. Future and more evolved generations will look back on this era of mankind in disbelief at the behavior of the pharmaceutical companies in alliance with Psychiatry and their disgraceful behavior .
For more on the whole Seroxat/Paxil story please check out my blog : http://truthman30.wordpress.com/ Posted by: Truthman at March 31, 2007 08:08 AM |
Patient Blogs. Sites.
The Trouble With Spikol
Icarus Project Blog John's Bipolar Stories Seroxat (Paxil) Sufferers Stand Up! Seroxat (Paxil) Secrets The Bipolar View Writhe Safely soulful sepulcher Electro Boy Spiritual Emergency Mental Nurse Deborah Gray Mental Mommy The Splintered Mind bipolar.and.me Nurse Ratched Psych Person Trick Cycling for Beginners depression introspection Salted Lithium Living With A Purple Dog Polar Trippin' Mercurial Scribe Bipolar Chicks Blogging Bipolar Blast Off Label Jung At Heart Graphic Truth Joysoup Apesma's Lament Soapy Water Outlaw Psychiatry Empirical Insanity Patient Anonymous Beyond Blue Psych Survivor Postpartum Progress The Happiness Project Finding Optimism The Gimp Parade Midlife and Treachery Secret Life of a Manic-Depressive Psych Tech Going Through Hell
Doctor Blogs. Sites.
Clinical Psych
World of Psychology CorePsych The Last Psychiatrist Carlat Report Blog Intueri Emotional Well-Being Scientific Misconduct Aaron Beck Cognitive Therapy Today Treatment Online Shrink Rap David Healy Dr. Dork NHS Blog Doctor Dr. X's Free Associations Dr. Sanity Anxious Mind Everyone Needs Therapy Counselling Resource
Activists. News.
Charlottesville Prejudice Watch
The Icarus Project MindFreedom AHRP Blog SSRI Stories Healthy Skepticism Psych Rights Treatment Advocacy Center Peter Breggin Schizophrenia News eDrugSearch Blog Nuts R Us News Disapedia WSJ Health Blog
Social Networking. Forums.
Mood Garden
Paxil Progress Crazy Boards Forums Psych Central Forums Icarus Project Forums DepressionTribe MySpace Bipolar Group Bipolar World Pendulum.org Bipolar Planet About.com Bipolar
Science. Big Pharma. Ethics.
PharmaLot
Pharma Gossip Science Blogs Mind Hacks GoozNews Integrity in Science Neurophilospohy bioethics.net Drug Wonks Pharma Marketing Blog Pharma's Cutting Edge On Pharma Health Care Renewal
Current Affairs
Buzz Machine
To The People Andrew Sullivan Michelle Malkin Daily Kos Reason's Hit&Run The Agitator Press Think Jim Romenesko Rough Type Gawker The Graphic Truth Tail Rank Huffington Post Instapundit Little Green Footballs Talking Points Memo MoJo Blog
Seattle Stuff
Smoking. Stuff.
|

